Pasireotide-d7 (TFA)

• Description :

  Pasireotide-d7 (TFA) is the deuterium labeled Pasireotide TFA[1].

• UNSPSC :

  12352005

• Target :

  Isotope-Labeled Compounds

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  Others

• Field of Research :

  Others

• Solubility :

  10 mM in DMSO

• Smiles :

  OC(C(F)(F)F)=O.O=C1N2[C@@](C(N[C@](C3=CC=CC=C3)([H])C(N[C@@H](C(N[C@H](C(N[C@H](C(N[C@H]1CC4=CC=CC=C4)=O)CC5=CC=C(C=C5)OC([2H])([2H])C6=C([2H])C([2H])=C([2H])C([2H])=C6[2H])=O)CCCCN)=O)CC7=CNC8=CC=CC=C78)=O)=O)([H])C[C@H](C2)OC(NCCN)=O.[3]

• Molecular Formula :

  C60H60D7F3N10O11

• Molecular Weight :

  1396.31

• References & Citations :

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported